Zevra Therapeutics Inc. Cash Flow Reinvestment Rate
Zevra Therapeutics Inc. cash flow reinvestment rate. Zevra Therapeutics Inc. (ZVRA) has a Cash Flow Reinvestment Rate of 1.09x as of September 2025, reinvesting $5.13 Million (capex $554.00K plus investments $-4.58 Million) from operating cash flow of $4.71 Million. Explore ZVRA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zevra Therapeutics Inc. (2021–2021)
Cash flow reinvestment rate of Zevra Therapeutics Inc. from 2021 to 2021. Historical reinvestment intensity for Zevra Therapeutics Inc. across 1 annual periods. Explore how much does Zevra Therapeutics Inc. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Zevra Therapeutics Inc. Cash Flow Reinvestment Rate by Year (2021–2021)
Zevra Therapeutics Inc. cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Zevra Therapeutics Inc.. For the full cash flow conversion analysis, see ZVRA cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.50x | $15.63 Million | $10.44 Million | $102.00K | — |